Atypical antipsychotics (except clozapine) (Various (except Clozaril® which is red))

NICE recommendations, summary of meeting discussions, links to additional supporting docs etc.

2002: Consultant initiation only.

Trust will supply atypical antipsychotics for new outpatients for the first three months if there are appropriate reasons to do this, ie unstable or difficult patient, inadequate support available.

NICE produced guidance on use of atypical anitpsychotics in June 2002 (TAG No. 43)

May 2009:

The TAG acknowledged NICE CG 82 Psychosis and schizophrenia: management which replaced TA 43 and CG 1.

May 2014:

The TAG acknowledged NICE CG 178 Psychosis and schizophrenia in adults: prevention and management ,which replaced CG 82

September 2016:  The NHS Norfolk & Waveney CCGs’ D&TCG supported the TAG’s recommendations and agreed that use of aripiprazole for schizophrenia and bipolar mood disorder is commissioned as Amber Initiate(GP prescribing following consultant initiation) in line with other antipsychotics.

July 2018:

The TAG noted and supported GP guidance on Physical Health monitoring related to prescribing in adults with psychoses (and related disorders)

July 2018:

The D&TC also acknowledged that the monitoring to be undertaken by GPs under the CCGs’ Local Enhanced Service agreement for monitoring drug treatments in primary care would be classified as Level “0” since GPs are already funded under the QoF.